Resources Contact Us Home
Monoclonal antibody to CD166 and method for production thereof

Image Number 2 for United States Patent #8003762.

CD166 is a cell adhesion molecule belonging to an immunoglobulin superfamily that is expressed in an excessive amount on the tumor surface. If an monoclonal antibody specifically binding to the CD166 is obtained, it becomes possible to suppress growth of tumor cells, detect the cells, and supply a therapeutic drug thereto specifically. However, because the CD166 proteins are very similar to each other among mammals, it was not possible to obtain an antibody to human CD166, by immunizing, for example, mice with the human CD166. The antibody was prepared by immunizing mice with a purified avian CD166 protein. The antibody was found to be adsorbed on human and mouse CD166 proteins in vitro as well as in vivo and to have an action to suppress tumor growth in mice.

  Recently Added Patents
Mirror drift compensation in an optical circuit switch
Method for execution upon processing of at least one histological sample
Tray for microwave cooking and folding of a food product
Systems and methods for providing live voicemail to a mobile handset
Redistribution layer (RDL) with variable offset bumps
PCSK9 antagonists
Integrated circuit package system with bonding lands
  Randomly Featured Patents
Hockey stick construction
Disk drive air filter assembly
Process for preparing heat-resistant polyurethane elastomers having no secondary softening range
Process for anisotropic carbon production
Modular overhead privacy system
Method and apparatus for wireless spread spectrum communication with preamble sounding gap
Implantable neural electrode
System and method for high-level test planning for layout
Rock bit and inserts with wear relief grooves
Process for the preparation of .epsilon.-caprolactam